These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 35859314)

  • 21. BNT162b2 Vaccine Booster and Mortality Due to Covid-19.
    Arbel R; Hammerman A; Sergienko R; Friger M; Peretz A; Netzer D; Yaron S
    N Engl J Med; 2021 Dec; 385(26):2413-2420. PubMed ID: 34879190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar.
    Abu-Raddad LJ; Chemaitelly H; Ayoub HH; AlMukdad S; Yassine HM; Al-Khatib HA; Smatti MK; Tang P; Hasan MR; Coyle P; Al-Kanaani Z; Al-Kuwari E; Jeremijenko A; Kaleeckal AH; Latif AN; Shaik RM; Abdul-Rahim HF; Nasrallah GK; Al-Kuwari MG; Butt AA; Al-Romaihi HE; Al-Thani MH; Al-Khal A; Bertollini R
    N Engl J Med; 2022 May; 386(19):1804-1816. PubMed ID: 35263534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant - United States, February 14-March 27, 2022.
    Prasad N; Derado G; Nanduri SA; Reses HE; Dubendris H; Wong E; Soe MM; Li Q; Dollard P; Bagchi S; Edwards J; Shang N; Budnitz D; Bell J; Verani JR; Benin A; Link-Gelles R; Jernigan J; Pilishvili T
    MMWR Morb Mortal Wkly Rep; 2022 May; 71(18):633-637. PubMed ID: 35511708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety of heterologous primary and booster schedules with ChAdOx1-S and BNT162b2 or mRNA-1273 vaccines: nationwide cohort study.
    Andersson NW; Thiesson EM; Laursen MV; Mogensen SH; Kjær J; Hviid A
    BMJ; 2022 Jul; 378():e070483. PubMed ID: 35831006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protection following BNT162b2 booster in adolescents substantially exceeds that of a fresh 2-dose vaccine.
    Amir O; Goldberg Y; Mandel M; Bar-On YM; Bodenheimer O; Ash N; Alroy-Preis S; Huppert A; Milo R
    Nat Commun; 2022 Apr; 13(1):1971. PubMed ID: 35418201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebellar and brainstem stroke possibly associated with booster dose of BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine.
    Thomas MG; Dermawan A; Teh S
    BMJ Case Rep; 2023 May; 16(5):. PubMed ID: 37147105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Humoral Response to Pfizer BNT162b2 Vaccine Booster in Maintenance Hemodialysis Patients.
    Shashar M; Nacasch N; Grupper A; Benchetrit S; Halperin T; Erez D; Rozenberg I; Shitrit P; Sela Y; Wand O; Cohen-Hagai K
    Am J Nephrol; 2022; 53(2-3):207-214. PubMed ID: 35172312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COVID-19 Vaccine Safety in Adolescents Aged 12-17 Years - United States, December 14, 2020-July 16, 2021.
    Hause AM; Gee J; Baggs J; Abara WE; Marquez P; Thompson D; Su JR; Licata C; Rosenblum HG; Myers TR; Shimabukuro TT; Shay DK
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(31):1053-1058. PubMed ID: 34351881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Adverse Reactions of Pfizer BioNTech COVID-19 Vaccine Booster Dose are Mild and Similar to the Second Dose Responses: A Retrospective Cross-Sectional Study.
    El-Shitany NA; Bagher AM; Binmahfouz LS; Eid BG; Almukadi H; Badr-Eldin SM; El-Hamamsy M; Mohammedsaleh ZM; Saleh FM; Almuhayawi MS; Alghamdi SA; Arab RA; Ali SS; Harakeh S; Alghamdi BS
    Int J Gen Med; 2022; 15():6821-6836. PubMed ID: 36051568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vulvar Aphthous Ulcer Following Pfizer-BioNTech COVID-19 Vaccine - A Case Report.
    Drucker A; Corrao K; Gandy M
    J Pediatr Adolesc Gynecol; 2022 Apr; 35(2):165-166. PubMed ID: 34718079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study.
    Jara A; Undurraga EA; Zubizarreta JR; González C; Pizarro A; Acevedo J; Leo K; Paredes F; Bralic T; Vergara V; Mosso M; Leon F; Parot I; Leighton P; Suárez P; Rios JC; García-Escorza H; Araos R
    Lancet Glob Health; 2022 Jun; 10(6):e798-e806. PubMed ID: 35472300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients.
    Rabinowich L; Grupper A; Baruch R; Ben-Yehoyada M; Halperin T; Turner D; Katchman E; Levi S; Houri I; Lubezky N; Shibolet O; Katchman H
    J Hepatol; 2021 Aug; 75(2):435-438. PubMed ID: 33892006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A First Report on Side-Effects of COVID-19 Vaccines among General Population in Sudan: A Cross-Sectional Analysis.
    Mohamed MS; Mohamed AO; Alenazy R; Khan YH; Idriss MT; Alhudaib NAA; Elsaman T; Mohamed MA; Eltayib EM; Mallhi TH
    Vaccines (Basel); 2023 Jan; 11(2):. PubMed ID: 36851192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Effect of Age, Gender and Comorbidities Upon SARS-CoV-2 Spike Antibody Induction After Two Doses of Sinopharm Vaccine and the Effect of a Pfizer/BioNtech Booster Vaccine.
    Farid E; Herrera-Uribe J; Stevenson NJ
    Front Immunol; 2022; 13():817597. PubMed ID: 35711448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged ≥16 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, September 2021.
    Dooling K; Gargano JW; Moulia D; Wallace M; Rosenblum HG; Blain AE; Hadler SC; Plumb ID; Moline H; Gerstein J; Collins JP; Godfrey M; Campos-Outcalt D; Morgan RL; Brooks O; Talbot HK; Lee GM; Daley MF; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2021 Sep; 70(38):1344-1348. PubMed ID: 34555007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atypical Presentation of Erythema Nodosum Following Pfizer-BioNTech COVID-19 Vaccine.
    Alzoabi N; Alqahtani J; Algamdi B; Almutairi M; Alratroot J; Alkhaldi S; Alqahtani S; Alakloby O
    Med Arch; 2022 Feb; 76(1):72-74. PubMed ID: 35422564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety Monitoring of an Additional Dose of COVID-19 Vaccine - United States, August 12-September 19, 2021.
    Hause AM; Baggs J; Gee J; Marquez P; Myers TR; Shimabukuro TT; Shay DK
    MMWR Morb Mortal Wkly Rep; 2021 Oct; 70(39):1379-1384. PubMed ID: 34591835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aeromedical Decision Making for Military Aircrew with Graves' Disease.
    Loh EH; Soh FW; See B; Tan BBC
    Aerosp Med Hum Perform; 2021 Dec; 92(12):980-986. PubMed ID: 34986938
    [No Abstract]   [Full Text] [Related]  

  • 39. Lymphatic osteopathic manipulative treatment reduces duration of deltoid soreness after Pfizer/BioNTech COVID-19 vaccine.
    Marshall S; Winter S; Capobianco JD
    J Osteopath Med; 2022 Jan; 122(3):153-157. PubMed ID: 35014768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Booster dose of the Pfizer/BioNTech COVID-19 vaccine (Comirnaty).
    Med Lett Drugs Ther; 2021 Oct; 63(1635):161-162. PubMed ID: 35050241
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.